Pfizer is expecting its covid windfall to end in 2023:
qz.com/pfizer-is-expecting-its-covid-windfall-to-end-in-2023-1850061387
Story Details
| Last Updated | Feb 05 23 |
| Total Articles | 2 |
More articles on this subject
Previous
US FDA approves Pfizer's gene therapy for rare bleeding disorder: The U.S. Food and Drug Administration approved Pfizer's gene therapy for hemophilia B on Friday ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-pfizers-gene-therapy-rare-bleeding-disorder-2024-04-26/
Quick Glance: FDA approves Pfizer’s gene therapy for hemophilia B
- The FDA has approved Pfizer's first gene therapy drug for a rare inherited bleeding disorder.
- Beqvez, a unique gene therapy drug by Pfizer, has been approved for adults with moderate to severe hemophilia B.
- The drug enables patients to produce Factor IX themselves to prevent and control bleeding.
- Pfizer is competing with a similar treatment from CSL Behring and planning more gene therapies for various genetic disorders.
Pfizer vs Moderna battle over COVID vaccine patents begins in UK: Pfizer and BioNTech asked a London court to revoke rival Moderna's patents over technology key ...
reuters.com/business/healthcare-pharmaceuticals/pfizer-vs-moderna-battle-over-covid-vaccine-patents-begins-uk-2024-04-23/
Bristol Myers Squibb drafts contingency plans for US restrictions on Chinese pharma
ft.com/content/f3b5f2e5-1abc-4848-8ff2-66891d5f5984
Dividend Harvesting Portfolio Week 164: $16,400 Allocated, $1,466.94 In Projected Dividends
seekingalpha.com/article/4685001-dividend-harvesting-portfolio-week-164-16400-allocated-1466-94-in-projected-dividends
Paid articlePaid
Big Pharma Stocks Need a Rethink. Investors Keep Making the Same Mistake.: Pfizer’s patent expirations are great for humanity but terrible for investors ...
barrons.com/articles/big-pharma-stocks-investors-mistakes-90e3c575
Paid articlePaid Pfizer Receives FDA Approval for Bleeding Disorder Treatment: The treatment, Beqvez, is for adults with moderate to severe hemophilia B.
barrons.com/articles/pfizer-fda-bleeding-disorder-stock-price-dca9b947
Paid articlePaid Ad group WPP trails rivals with decline in organic revenue: Britain's WPP became a clear laggard among global ad companies with a drop in organic revenue drop in ...
reuters.com/business/media-telecom/ad-group-wpp-reports-16-drop-first-quarter-organic-growth-2024-04-25/
Swiss pharma giant Roche's first-quarter sales edge higher as its emerges from post-Covid-19 slump
cnbc.com/2024/04/24/swiss-pharma-giant-roches-first-quarter-sales-edge-higher-as-its-emerges-from-post-covid-19-slump.html
Pfizer RSV shot meets goals in trial of high-risk adults under age 60: Pfizer said on Tuesday its respiratory syncytial virus (RSV) vaccine Abrysvo was well ...
reuters.com/business/healthcare-pharmaceuticals/pfizer-rsv-shot-meets-goals-trial-high-risk-adults-under-age-60-2024-04-09/
The Best Defensive Stocks to Buy: These 10 defensive stocks supply investors with reliable earnings, and often dividends, when markets look uncertain.
morningstar.com/stocks/best-defensive-stocks-buy
Blackstone nears deal to sell S.Korean pharma wholesaler to MBK Partners, sources say
reut.rs/3U84zcy
Pfizer wins pause on Moderna's COVID-19 patent lawsuit: Moderna's patent lawsuit claiming Pfizer and BioNTech copied its COVID-19 vaccine technology will be put ...
reuters.com/legal/litigation/pfizer-wins-pause-modernas-covid-19-patent-lawsuit-2024-04-12/
AbbVie's newer drugs are offsetting losses of the world's once best-selling medication
qz.com/abbvie-humira-q1-sales-1851438282
"Misleading claims": The UK audit authority criticizes the pharmaceutical company Pfizer. The vaccine against Covid-19 was illegally advertised on social media ...
weltwoche.ch/daily/irrefuehrende-behauptungen-die-britische-pruefbehoerde-kritisiert-den-pharmakonzern-pfizer-in-den-sozialen-medien-sei-illegal-fuer-den-impfstoff-gegen-covid-19-geworben-worden/
Drug sales keep beating Wall Street's expectations and boosting some pharma stocks
qz.com/pharma-sales-q1-1851435519
Goldman Sachs: The Best Dividend Growth Stocks for Investors to Watch Now: Goldman Sachs recommends high-dividend stocks for 2024 with over 6% growth.
boerse-online.de/nachrichten/aktien/goldman-sachs-die-besten-dividendenwachstumsaktien-die-fuer-anleger-jetzt-interessant-sind-20355982.html
Drugmakers' low U.S. taxes belie their high sales: Most of the largest pharmaceutical companies report losing money in the United States ...
npr.org/sections/health-shots/2024/04/15/1244876740/drugmakers-low-taxes-us
Nuclear medicine is big pharma's new target in cancer race: Biotechs work on injected radioactive drugs to target tumors
gulfnews.com/lifestyle/health-fitness/nuclear-medicine-is-big-pharmas-new-target-in-cancer-race-1.1712928209636
Were COVID-19 Vaccines to Blame for Infertility? Heart Attacks? A New Report Weighs In
usnews.com/news/health-news/articles/2024-04-16/were-covid-19-vaccines-to-blame-for-infertility-heart-attacks-a-new-report-weighs-in
Now the EU public prosecutor's office is also investigating von der Leyen - and the German media is still silent - The World Week
weltwoche.de/daily/nun-ermittelt-auch-die-eu-staatsanwaltschaft-gegen-von-der-leyen-und-die-deutschen-medien-schweigen-noch-immer/
Weight-loss drug startup Metsera wants to take on Novo and Lilly. Here’s what you need to know
fastcompany.com/91110090/metsera-startup-eli-lilly-novo-nordisk-competitor-weight-loss-drugs
The 2024 Forbes Entrepreneurial CMO 50 List: By The Numbers: The data and details behind the CMOs and marketers making the 2024 Forbes Entrepreneurial CMO 50 ...
forbes.com/sites/sethmatlins/2024/04/15/the-2024-forbes-entrepreneurial-cmo-50-list-by-the-numbers/
Pfizer RSV Vaccine Could Get Wider Use. New Study Suggests a Benefit For All Adults.
barrons.com/articles/pfizer-fda-rsv-vaccine-shot-gsk-moderna-4b1d50cc
Paid articlePaid Activist investor blasts Novavax for not using mRNA fears to boost COVID-19 vaccine sales
qz.com/novavax-covid19-mrna-1851410267
Quick Glance: Criticism of Novavax for Missed Opportunities in Boosting COVID-19 Vaccine Sales
- Shah Capital called for immediate changes in the company's board.
- The activist hedge fund Shah Capital criticized Novavax's leadership for not capitalizing on concerns some individuals have about mRNA vaccines to increase sales of its traditional, protein-based COVID-19 vaccine.
- Findings from a survey of 1,500 Americans by the Annenberg Public Policy Center (APPC) at the University of Pennsylvania revealed an increase in the spread of vaccine misinformation.
- The limited use of COVID-19 vaccines is also affecting other vaccine manufacturers. In the U.S., only 14% of adults have received an updated COVID-19 vaccine for 2023-2024, according to the Centers for Disease Control and Prevention.
Moderna's new cancer vax, AstraZeneca CEO's big pay, and record-high drug shortages: Pharma news round up
qz.com/moderna-cancer-vax-astrazeneca-ceo-pay-drug-shortages-1851404812
Recall of 'Benylin' drug batch occasioned by contamination concerns: Benylin recall serves as a stark reminder of the importance of stringent quality ...
standardmedia.co.ke/health/health-science/article/2001493198/recall-of-benylin-drug-batch-occasioned-by-contamination-concerns
Morgan Stanley bullish on biotech: That's why Pfizer and Co's shares could soon take off
boerse-online.de/nachrichten/aktien/morgan-stanley-bei-biotech-bullisch-darum-koennten-die-aktien-von-pfizer-und-co-bald-richtig-abgehen-20354537.html
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology: GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday ...
reut.rs/3UzZgE8
Markets bounce back from intra-day lows! Sensex up 480 points, Nifty closes above 22,550 led by PSU banks and pharma stocks
financialexpress.com/market/markets-bounce-back-from-intra-day-lows-sensex-up-480-points-nifty-closes-above-22550-led-by-psu-banks-and-pharma-stocks-3468389/
Pneumococcal vaccine: Apexxnar® becomes Prevenar 20®: The pneumococcal vaccine Apexxnar® is no longer only approved for adults aged 18 and over ...
ptaheute.de/aktuelles/2022/04/27/neuer-pneumokokken-impfstoff-fuer-erwachsene
Tübingen-based pharmaceutical company Curevac wants to cut costs - Business news - Reutlinger General-Anzeiger - gea.de
gea.de/neckar-alb/wirtschaft-in-der-region_artikel,-t%C3%BCbinger-pharma-unternehmen-curevac-will-kosten-senken-_arid,6893681.html
LA Times ‘Trapped in a Mess’ as Owner Patrick Soon-Shiong Pulls More Newsroom Strings | Exclusive
thewrap.com/los-angeles-times-staff-upset-patrick-soon-shiong/
From nowhere to a lifesaver: The year 1982 was a watershed in the history of the pharmaceutical industry of Bangladesh as the government stepped in to lay the ...
thedailystar.net/business/economy/news/nowhere-lifesaver-3596251
Critical Medicines Alliance is 'wake-up call', says French minister of industry: The Critical Medicines Alliance, launched in Brussels on Wednesday (April 24) ...
euractiv.com/section/all/news/alliance-des-medicaments-critiques-roland-lescure-salue-un-reveil-collectif-europeen/
EU Commission establishes alliance for critical medicines: Berlin - An alliance for critical medicines is intended to help combat supply bottlenecks for ...
aerzteblatt.de/nachrichten/150999/EU-Kommission-gruendet-Allianz-fuer-kritische-Arzneimittel
Drug distributor Cardinal Health to lose OptumRx contracts: Cardinal Health said on Monday its contracts with UnitedHealth Group's OptumRx ...
reuters.com/business/healthcare-pharmaceuticals/cardinal-health-says-contracts-with-unitedhealths-optumrx-will-not-be-renewed-2024-04-22/
Corona has long been a thing of the past - now the pharmaceutical giant Roche has also survived the aftermath
diepresse.com/18399963/corona-ist-lange-passe-nun-hat-auch-der-pharma-riese-roche-die-nachwehen-ueberstanden
HSV billionaire Kühne takes over large pharmaceutical company in Hildesheim district
hildesheimer-allgemeine.de/meldung/hsv-milliardaer-kuehne-uebernimmt-grosses-pharma-unternehmen-im-landkreis-hildesheim.html
Quarterly figures: Pfizer loss pushes WPP's balance sheet down: The advertising holding WPP has presented its business figures for the first quarter of 2024 ...
horizont.net/agenturen/nachrichten/quartalszahlen-pfizer-verlust-drueckt-die-bilanz-von-wpp-nach-unten-219520
Paid articlePaid
Irish-founded Nutriband raises millions in fresh funding: Company intends to file for FDA approval for its proprietary abuse-deterrent technology
businesspost.ie/news/irish-founded-nutriband-raises-millions-in-fresh-funding/
Paid articlePaid
Pharma exports rise around 10% to $27.9 billion, US biggest importer: The country's drugs and pharmaceuticals exports increased 9.67 per cent year-on-year to USD ...
business-standard.com/industry/news/pharma-exports-rise-around-10-to-27-9-billion-us-biggest-importer-124042400568_1.html
How drug prices are negotiated in Switzerland and beyond - SWI swissinfo.ch: Switzerland's pharmaceutical sector supplies drugs worldwide ...
swissinfo.ch/eng/multinational-companies/who-decides-drug-prices-and-how/75914703
Bosnian police arrest 23 suspected of being part of drug lord's circle: The world-notorious kingpin was arrested in 2022 and ultimately sentenced to seven ...
euronews.com/2024/04/23/police-in-bosnia-arrest-23-suspected-members-of-drug-kingpins-inner-circle
The federal government wants to improve the framework conditions for the pharmaceutical industry
dlvr.it/T5vT2T
Xarelto®: First generics on sale: The patent for Xarelto® has expired and rivaroxaban generics have been listed in the Lauer tax for the first time since April ...
ptaheute.de/aktuelles/2024/04/23/xarelto-r-erste-generika-im-handel
MBK Partners acquires pharmaceutical wholesaler Geo-Young from Blackstone: MBK Partners has acquired a major stake in pharmaceutical wholesaler Geo-Young ...
koreatimes.co.kr/www/biz/2024/04/175_373212.html
Bangladesh produces biologic drug in milestone achievement : Experts hoped that the new drug would enrich the local pharmaceutical industry further if there is ...
en.prothomalo.com/bangladesh/8i0mm8moxu
Körber is now expanding: a new building is scheduled to be built by 2026: Construction work on the new building for Körber Pharma Packaging AG in the Grabs ...
wundo.ch/artikel/koerber-baut-jetzt-aus-bis-2026-soll-ein-neubau-entstehen/
Paid articlePaid
Low-carb diets work. Why does the American Diabetes Association push insulin instead?
theguardian.com/commentisfree/2024/apr/17/ada-american-diabetes-association-big-pharma
French Greens’ top candidate wants 'European pharmaceutical sovereignty': Marie Toussaint, the lead of the French Greens' campaign for the June European ...
euractiv.com/section/health-consumers/news/french-greens-top-candidate-wants-european-pharmaceutical-sovereignty/
Unveiling Pfizer's Potent Cocktail: Key Drivers Of Free Cash Flow Growth: Pfizer announced positive results from a pivotal clinical trial evaluating Abrysvo's ...
seekingalpha.com/article/4684677-pfizer-stock-key-drivers-of-free-cash-flow-growth
Paid articlePaid Goldman Sachs: The experts are now betting on these new growth stocks: New high ROE growth stocks added by Goldman Sachs, including Amazon, Uber and Pfizer.
boerse-online.de/nachrichten/aktien/goldman-sachs-auf-diese-neuen-wachstumsaktien-setzen-die-experten-jetzt-20355554.html
The quiet heroes behind the electoral bonds stories: Reporters who file daily stories are the ones who make the big stories possible
thehindu.com/opinion/op-ed/the-quiet-heroes-behind-the-electoral-bonds-stories/article68079093.ece
Inside Novartis' Outsized Play In India - Forbes India: Forbes India's Manu Balachandran talks about Vasant 'Vas' Narasimhan, CEO, Novartis ...
forbesindia.com/audio/audio/inside-novartis-outsized-play-in-india/92631
Meet Premchand Godha, the man who transformed a struggling company into a Rs 28,000 crore pharma giant with Amitabh Bachchan
financialexpress.com/web-stories/lifestyle/meet-premchand-godha-the-man-who-transformed-a-struggling-company-into-a-rs-28000-crore-pharma-giant-with-amitabh-bachchan-2/
Qureight has raised $8.5 million for its AI techbio platform: AI techbio startup Qureight makes it easier for pharma companies to conduct clinical trials.
businessinsider.com/qureight-has-raised-8-5-million-ai-techbio-platform-2024-4
U.S. Scrutiny of Chinese Company Could Disrupt U.S. Supply Chain for Key Drugs: Lawmakers raising national security concerns and seeking to disconnect a major ...
nytimes.com/2024/04/15/health/wuxi-us-drugs-congress.html
Doubts about the Greek economic miracle: Greece is suffering from Europe's slump and needs further structural reforms. That is the tenor of the annual Delphi ...
faz.net/aktuell/wirtschaft/zweifel-am-griechischen-wirtschaftswunder-19651596.html
Paid articlePaid Serum Institute, Univercells tie-up for affordable personalised cancer care: SII was the world’s largest vaccine manufacturer with a global footprint of any ...
financialexpress.com/healthcare/news-healthcare/serum-institute-univercells-tie-up-for-affordable-personalised-cancer-care/3456066/
Pfizer's Doldrums, Just A Bad Case Of COVID-19?: Pfizer may be worth buying as the COVID-based product revenues decline and equilibrate ...
seekingalpha.com/article/4683994-pfizer-doldrums-just-a-bad-case-of-covid-19-pfe-stock
Paid articlePaid Several aces up his sleeve: Is this well-known pharmaceutical share currently available at a super savings price?
boerse-online.de/nachrichten/aktien/gleich-mehrere-asse-im-aermel-gibt-es-diese-bekannte-pharma-aktie-jetzt-gerade-zum-super-sparpreis-20355267.html
JPMorgan Hires Health-Care Banker Dass from Deutsche Bank: JPMorgan Chase & Co. has hired health-care banker Christopher Dass from Deutsche Bank AG as a ...
bloomberg.com/news/articles/2024-04-15/jpmorgan-hires-health-care-banker-dass-from-deutsche-bank
Paid articlePaid Novartis: Innovating For The World, From India - Forbes India: How Vasant 'Vas' Narasimhan is readying India to play a bigger role in its medicines ...
forbesindia.com/article/leadership/novartis-innovating-for-the-world-from-india/92575/1
EU partners Nigeria to boost local vaccine production: The European funding, allocated under the Team Europe Initiative on Manufacturing and Access to Vaccines ...
punchng.com/eu-partners-nigeria-to-boost-local-vaccine-production/
Kara Swisher calls out urgent need for AI guardrails: Famed journalist and author Kara Swisher joined TheStreet to discuss the pressing need for AI regulations ...
star-telegram.com/news/business/article287655870.html
Paid articlePaid
Bridging the pharma-business gap: AS most of Malaysia’s pharmaceutical and cosmetic products are imported, it is crucial that we expand the capabilities of our ...
thestar.com.my/news/education/2024/04/14/bridging-the-pharma-business-gap
Moderna's new cancer vax, AstraZeneca CEO's big pay, and record-high drug shortages: Pharma news round up
qz.com/moderna-cancer-vax-astrazeneca-ceo-pay-drug-shortages-1851404812
AstraZeneca’s Pascal Soriot ‘massively underpaid’ at £16.9mn, says top shareholder
ft.com/content/c7226781-b45b-4502-ba38-129dea5e960e
Sales rumors! Is this biotech company changing hands soon?: Janux Therapeutics considers sale following takeover interest.
deraktionaer.de/artikel/pharma-biotech/verkaufsgeruechte-wechselt-diese-biotech-firma-bald-den-besitzer-20355065.html
Sweden aims to keep current data protection period in EU pharma package: The Swedish government is opposed to shortening the regulatory data protection period ...
euractiv.com/section/health-consumers/news/sweden-aims-to-keep-current-data-protection-period-in-eu-pharma-package/
Belgium’s university-industry collaboration model could accelerate EU's advanced therapeutics
euractiv.com/section/health-consumers/news/belgiums-university-industry-collaboration-model-could-accelerate-eus-advanced-therapeutics/
5 Top Dividend Stocks to Buy From the Best Managers: These cheap dividend stocks are popular among highly rated concentrated fund managers.
morningstar.com/stocks/5-top-dividend-stocks-buy-best-managers
ENVI's EU pharma package 'a bloody compromise' says Czech shadow rapporteur: EP votes on Wednesday (10 April) on the new pharmaceutical legislation ...
dlvr.it/T5HDbC
Big Pharma Stocks Need a Rethink. Investors Keep Making the Same Mistake.: Pfizer’s patent expirations are great for humanity but terrible for investors ...
barrons.com/articles/big-pharma-stocks-investors-mistakes-90e3c575
Paid articlePaid
Germany's factory orders back to growth in February: New orders in manufacturing up 0.2% month-on-month in February, shifting from January's 11.4% decline ...
yenisafak.com/en/news/germanys-factory-orders-back-to-growth-in-february-3680756
Paid articlePaid
Vaccine deal with Pfizer: Ursula von der Leyen in the sights of corruption hunters
rundschau-online.de/red/impfstoff-deal-mit-pfizer-von-der-leyen-im-visier-der-korruptionsjaeger-770493
Pfizer: Enormous competition: The market is considered competitive.
deraktionaer.de/artikel/pharma-biotech/pfizer-enorme-konkurrenz-20354418.html
Regeneron to collaborate on gene editing therapies with Doudna-founded Mammoth: Regeneron Pharmaceuticals and Mammoth Biosciences will collaborate to research ...
reuters.com/business/healthcare-pharmaceuticals/regeneron-collaborate-gene-editing-therapies-with-doudna-founded-mammoth-2024-04-25/
Next
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics